Alyftrek, a next-generation triple-combination CFTR modulator, further improved the function of the defective CFTR protein in children ages 2…
Articles by Marisa Wexler, MS
Tactile Systems Technology has announced the commercial launch of a next-generation version of its AffloVest system, a high-frequency chest…
Macrophages from people with cystic fibrosis (CF) showed multiple defects that may make it harder for them to kill…
For people with cystic fibrosis (CF), the decision of whether or not to become a parent is fraught with…
ETD001, an inhaled therapy for cystic fibrosis (CF), appeared to work better than a placebo at improving lung function…
An early clinical trial testing inhaled cystic fibrosis (CF) treatment VX-522 — being developed for adults with CF who are…
Trikafta (elexacaftor/tezacaftor/ivacaftor) is generally effective at easing sinus issues in people with cystic fibrosis (CF) who have already…
Advocates around the globe are gearing up for a variety of events and digital…
A small clinical trial testing Sionna Therapeutics‘ SION-719 as an add-on treatment for cystic fibrosis (CF) — to…
People with cystic fibrosis (CF) taking Trikafta usually report notable improvements in their quality of life — even…